The medication itself doesnt usually affect sleep, but lifestyle changes might
3 After propensity-score matching for age, BMI, breast density, race, ethnicity, and diabetes history (n=30,528), breast cancer occurred in 1.62% (247/15,264) of GLP-1 users over the study period of 3.5 years, compared with 2.31% (353/15,264) of matched non-users
KLOW has not been evaluated in formal human clinical trials, so any extrapolation to human safety is speculative
found that LncRNA UCA1 can specifically bind to and promote the interaction between heteronuclear ribonucleoprotein (hnRNP I/L) and the GPT2 promoter, resulting in increased GPT2 expression, which subsequently enhances the Gln-fueled TCA cycle and tumor development (62)
Let us walk through it